Anti-Aging Supplements That Actually Work for Men (Evidence-Based)

Supplements sold to men as anti-aging products are a large market, and most of the money goes to marketing, not molecules.

A small set of compounds have human trial data behind them: randomized controlled trials with measured outcomes in people, not only cell or mouse studies. Some of those trials were positive, and some of the biggest were null on their main question. This guide ranks the compounds by evidence quality, says which results were primary and which were secondary, and gives the doses the trials used.

This guide is for men over 40 who want to cut through supplement marketing and find compounds with actual human evidence behind them.

In This Guide

• How to Read the Evidence
• Tier 1: Solid Human Trial Evidence
• Tier 2: Human Data Exists, Full Picture Pending
• What Doesn't Work
• The Practical Stack
• FAQ

Key Takeaways

• Omega-3 (EPA/DHA): In the VITAL trial of 25,871 adults, 1g/day did not reduce major cardiovascular events or cancer (the main outcomes). Total heart attacks were lower, a secondary result. A 2020 Cochrane review found a slight reduction in coronary heart disease events.
• Vitamin D3: VITAL's 2,000 IU/day arm did not reduce cancer or cardiovascular events. Cancer deaths were lower only after the first two years were excluded, a secondary analysis. About 42% of US adults had levels at or below 20 ng/mL in 2005-2006 NHANES data.
• Magnesium: In a meta-analysis of cohort studies, each extra 100mg of daily intake was associated with 10% lower all-cause mortality. About half of Americans eat less than the requirement.
• Creatine monohydrate: Meta-analyses of trials in older adults show more lean tissue and strength with resistance training, and better memory scores in adults aged 66 to 76.
• NMN / NR: Small human trials show both raise blood NAD+. Effects on health outcomes in people are not established.
• Berberine: In a small 3-month trial in newly diagnosed type 2 diabetes, berberine lowered blood glucose about as much as metformin. Best discussed with your doctor if you have metabolic risk factors.
• Resveratrol: Extensive hype, poor human bioavailability, no convincing human outcome data. Skip it.

How to Read the Evidence

"Backed by science" appears on supplements tested only in petri dishes. Before covering each compound, here is the evidence framework this article uses.

Tier 1: Human RCT evidence. Randomized controlled trials in humans measuring outcomes that matter, mortality, cardiovascular events, metabolic markers. This is the only category worth acting on.

Tier 2: Human trials with intermediate markers. Studies showing biological changes in humans (NAD+ levels, glucose, senescent cell counts) without long-term mortality data yet. Promising but incomplete.

Not worth it: Animal or mechanistic only. We know the pathway. We know it works in mice. Whether it translates to human outcomes is unknown. These get the skip.

Tier 1: Solid Human Trial Evidence

1. Omega-3 Fatty Acids (EPA/DHA)

The VITAL trial is the reference point for omega-3 in healthy people. It enrolled 25,871 US adults (men 50 and older, women 55 and older) without prior cardiovascular disease, randomized them to 1g/day of marine omega-3 or placebo, and followed them for a median of 5.3 years (Manson et al., 2019, NEJM). The main result was null: major cardiovascular events (HR 0.92, 95% CI 0.80-1.06) and invasive cancer did not fall. Among secondary outcomes, total heart attacks were lower (HR 0.72, 0.59-0.90) and fatal heart attacks were lower (13 vs 26 events; HR 0.50, 0.26-0.97). Deaths from all causes did not change. The authors called a possible benefit in people who ate little fish hypothesis-generating.

A 2020 Cochrane review of 86 trials (162,796 people) found little or no effect of long-chain omega-3 on all-cause mortality or cardiovascular events, a slight reduction in coronary heart disease events (RR 0.91, 0.85-0.97) and possibly coronary deaths (RR 0.90, 0.81-1.00), low-certainty evidence. Effects did not differ by dose. For high triglycerides, the American Heart Association reports that prescription omega-3 at 4g/day lowers very high triglycerides by 30% or more.

That is a modest, mixed record, and it comes from large trials, which is more than most longevity products can show.

Dosing: VITAL used 1g/day. If your triglycerides are high, talk to your doctor: the 4g/day doses in the AHA advisory are prescription products. Algae-based omega-3 is an option for men avoiding fish products.

2. Vitamin D3 + K2

The same VITAL trial tested 2,000 IU/day of vitamin D3 (Manson et al., 2019, NEJM). Vitamin D did not lower either main outcome: invasive cancer (HR 0.96, 0.88-1.06) and major cardiovascular events (HR 0.97, 0.85-1.12). Deaths from any cause did not change. Cancer deaths, a secondary outcome, were not significantly lower overall (HR 0.83, 0.67-1.02). In a prespecified analysis that excluded the first two years of follow-up, cancer deaths were lower (HR 0.75, 0.59-0.96). That is a secondary finding, not a proven 25% cut.

Low vitamin D is common. In NHANES 2005-2006 data, 41.6% of US adults had serum 25-OH vitamin D at or below 20 ng/mL, with higher rates in Black and Hispanic adults (Forrest and Stuhldreher, 2011). The Institute of Medicine's 2011 review found the evidence linking vitamin D to cancer, heart disease and other non-bone outcomes inconsistent and not proven to be causal.

The case for adding K2 is observational. In the Rotterdam Study of 4,807 adults, the top third of dietary menaquinone (K2) intake had lower coronary heart disease death (RR 0.43, 0.24-0.77) and less severe aortic calcification than the bottom third (Geleijnse et al., 2004). That is an association with K2 from food, not a trial of K2 supplements. K2 supplements can interfere with warfarin-type blood thinners: in a 2013 study, MK-7 doses as low as 10 mcg a day shifted anticoagulation in some people taking acenocoumarol (Theuwissen et al., Journal of Thrombosis and Haemostasis). If you take a blood thinner, talk to your doctor before adding K2.

Dosing: VITAL used 2,000 IU of D3 a day. Ask your doctor about a 25-OH vitamin D blood test before starting, and about the right dose if your level is low. For full dosing detail, see Vitamin D Dosage for Men Over 40.

3. Magnesium

Magnesium is easy to overlook. In 2005-2006 US survey data, 48% of Americans ate less magnesium than they need (Rosanoff et al., 2012, Nutrition Reviews). Magnesium takes part in over 600 enzymatic reactions, including energy metabolism and protein synthesis (de Baaij et al., 2015, Physiological Reviews).

A 2016 dose-response meta-analysis of 40 prospective cohort studies (more than 1 million people) in BMC Medicine found each 100mg/day increase in dietary magnesium associated with 10% lower all-cause mortality (RR 0.90, 0.81-0.99), 22% lower heart failure risk and 7% lower stroke risk, but no link with total cardiovascular disease or coronary heart disease (Fang et al., 2016). These are association studies of magnesium from food, not trials of supplements.

Form matters. In a small absorption study, magnesium oxide had a fractional absorption of about 4%, while magnesium chloride, lactate and aspartate absorbed better and about equally (Firoz and Graber, 2001, Magnesium Research).

Dosing: The cohort data are about diet, so food comes first. If you supplement, avoid relying on magnesium oxide. Talk to your doctor first if you have kidney disease. For the full evidence base, see Magnesium Supplement Benefits for Men.

4. Creatine Monohydrate

The case for creatine reaches beyond muscle performance into memory and muscle preservation.

A 2023 meta-analysis in Nutrition Reviews (Prokopidis et al.) pooled 8 randomized trials in healthy people and found creatine improved memory scores modestly overall. The effect was clear in adults aged 66 to 76 and absent in people aged 11 to 31.

For muscle, the mortality link runs through muscle mass. In 21,938 US adults in NHANES followed for a median of 10.9 years, higher appendicular muscle mass was associated with lower all-cause mortality (Cheng et al., 2025, Scientific Reports). That is an association. A 2017 meta-analysis of 22 trials (721 men and women, average ages 57 to 70) found creatine plus resistance training added 1.37 kg more lean tissue and more chest and leg press strength than training alone (Chilibeck et al., 2017, Open Access Journal of Sports Medicine).

The International Society of Sports Nutrition's 2017 position stand found creatine safe and well tolerated in healthy people at up to 30g a day for 5 years (Kreider et al., 2017). For the full evidence, see Creatine for Men Over 40.

Dosing: 3-5g creatine monohydrate per day, the ISSN maintenance range. No loading protocol needed. Creatine also pairs well with Zone 2 cardio training and resistance work as the foundation of a longevity fitness protocol.

Tier 2: Human Data Exists, Full Picture Pending

5. NMN and Nicotinamide Riboside (NR)

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to energy metabolism, DNA repair through PARP enzymes, and sirtuin activation. Sirtuins regulate gene expression, stress response, and cellular repair. In rodents, aging and obesity impair NAD+ production (Yoshino et al., 2021).

Two oral precursors raise NAD+ in humans: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside).

The human trials are small and short. A 2021 trial in Science (Yoshino et al., Washington University) found NMN 250mg/day for 10 weeks improved muscle insulin sensitivity in overweight or obese postmenopausal women with prediabetes. A 2022 trial in npj Aging gave healthy older Japanese men 250mg/day of NMN for 6 or 12 weeks: blood NAD+ rose, it was well tolerated, and gait speed and grip showed nominal improvements the authors said need confirming. For NR, a 2016 pharmacokinetic study in Nature Communications (Trammell et al.) found single doses of 100, 300 and 1,000mg raised blood NAD+ metabolites in a dose-dependent way. A 2018 crossover trial (Martens et al., Nature Communications) gave healthy middle-aged and older adults 1,000mg/day of NR for 6 weeks: NAD+ metabolism rose, and blood pressure and aortic stiffness trended lower, but those changes were not significant after correction for multiple comparisons.

What we do not have: trials showing that raising NAD+ improves health outcomes or lifespan in people. The biomarker data are early. If you are considering these, talk to your doctor.

Dosing: The trials above used NMN 250mg/day and NR 1,000mg/day. Store as the label directs.

6. Berberine

Berberine is a plant alkaloid found in barberry and goldenseal. Laboratory and animal studies show it affects glucose and lipid metabolism (Yin et al., 2008).

A 2008 pilot study in Metabolism (Yin et al.) randomized 36 adults with newly diagnosed type 2 diabetes to berberine or metformin, 0.5g three times a day for 3 months. Berberine lowered blood glucose about as much as metformin: HbA1c fell from 9.5% to 7.5% and fasting glucose from 10.6 to 6.9 mmol/L in the berberine group. In a second group of 48 adults with poorly controlled diabetes, adding berberine lowered HbA1c and total and LDL cholesterol. About a third (34.5%) had passing gastrointestinal side effects.

These are small, short trials in people with diabetes. Berberine is not a substitute for dietary change or prescribed medication. If you have insulin resistance or other metabolic risk factors, talk to your doctor about whether it fits.

Dosing: The Yin trial used 0.5g three times a day with meals. Berberine raises blood levels of some drugs: in kidney transplant patients it raised cyclosporine levels (Wu et al., 2005). Check with your doctor before starting if you take any prescription medication.

7. Fisetin and Quercetin (Senolytics)

Senescent cells are cells that have stopped dividing but do not die. They accumulate with age and can release inflammatory factors (the senescence-associated secretory phenotype, or SASP) that cause tissue dysfunction (Hickson et al., 2019). In mice, senescent cells have been shown to drive aging and age-related disease (Yousefzadeh et al., 2018).

Senolytics aim to remove senescent cells. The human data so far come from quercetin combined with dasatinib, a prescription cancer drug. In a 2019 open-label pilot in EBioMedicine, 14 patients with idiopathic pulmonary fibrosis took dasatinib plus quercetin 3 days a week for 3 weeks; walking distance, gait speed and chair stands improved, while lung function did not change and effects on senescence markers in blood were inconclusive (Justice et al.). In a second 2019 pilot, 9 people with diabetic kidney disease took a 3-day course, and senescent cells in fat tissue and skin fell 11 days later (Hickson et al.). Fisetin, a flavonoid found in strawberries, was the most potent of 10 flavonoids tested and extended lifespan in mice (Yousefzadeh et al., 2018). A fisetin trial in knee osteoarthritis (NCT04210986) is listed as completed.

These are small, early human studies in sick patients, without placebo groups, plus mouse data. None tested quercetin or fisetin alone as an anti-aging supplement in healthy men. This is a category to monitor, not one to act on.

If exploring: Senolytic protocols in trials are intermittent, not daily, and the human studies paired quercetin with a prescription drug. Do not try this without your doctor.

What Doesn't Work

Resveratrol. Early laboratory studies linked it to sirtuin activation, which generated large commercial interest. The clinical problem is bioavailability: in a 2004 study of six volunteers, at least 70% of an oral dose was absorbed, but only trace amounts of unchanged resveratrol reached the blood because the gut and liver convert it so fast (Walle et al., Drug Metabolism and Disposition). In a 2013 randomized trial in Diabetes, 24 obese men took high-dose resveratrol or placebo for 4 weeks, and insulin sensitivity, blood pressure, body fat and metabolic markers did not change (Poulsen et al.). Skip standard resveratrol products.

Telomere supplements. Products claiming to extend telomeres, typically through astragalus extracts or cycloastragenol, lack convincing human evidence. Whether any of them lengthen telomeres in human tissue, and whether that would improve health, is not established.

Proprietary anti-aging blends. A product listing 20+ ingredients without disclosed doses per ingredient cannot be evaluated. You cannot verify whether any active compound is present at a dose used in clinical trials. Individual compounds at research-validated doses beat combination products at unknown doses every time.

The Practical Stack

For men over 40 building a supplement protocol around longevity evidence, this is the priority order.

Foundation tier (discuss with your doctor, especially testing):

1. Omega-3 (EPA+DHA): 1g/day, the VITAL dose
2. Vitamin D3: dose based on a blood test; VITAL used 2,000 IU/day. K2 only after checking with your doctor if you take a blood thinner
3. Magnesium from food first; if supplementing, not the oxide form

Physical and cognitive longevity: 4. Creatine monohydrate: 3-5g/day

NAD+ support (experimental): 5. NMN 250mg/day or NR 1,000mg/day were the trial doses; outcome benefits are unproven

Metabolic health (only with your doctor, if relevant risk factors apply): 6. Berberine, as dosed in the trials above

None of these replace the foundational behaviors that drive longevity outcomes: sleep quality, cardiovascular training, and resistance exercise. They sit on top of that base. For a full picture of where supplements fit relative to lifestyle factors, see 15 Longevity Habits Every Man Over 40 Should Adopt.

Track whether your interventions are working. A biological age test gives you measurable feedback on whether your protocol is moving your biological clock in the right direction.

FAQ

What anti-aging supplements actually work for men over 40?

Creatine has the clearest trial evidence (more lean tissue and strength with training in older adults). Omega-3 and vitamin D have the largest trials, but VITAL was null on its main outcomes; heart attacks (omega-3) and cancer deaths after two years (vitamin D) were lower only in secondary analyses. Magnesium intake is linked to lower mortality in cohort studies. NMN and NR raise NAD+ in small trials; health outcomes are unproven.

Do NMN and NR supplements actually work?

They raise NAD+ levels in humans in small trials. A 2022 trial in healthy older men found 250mg/day of NMN for 6 to 12 weeks raised blood NAD+ and was well tolerated. Whether raising NAD+ improves health or extends lifespan in people has not been tested in long-term trials.

Is berberine as effective as metformin for longevity?

In a small 3-month trial in newly diagnosed type 2 diabetes, berberine and metformin lowered blood glucose and HbA1c by similar amounts. No trial has tested berberine for longevity, and it lacks metformin's long safety record. Men with type 2 diabetes should work with their doctor rather than substituting berberine for a prescribed treatment.

How long before these supplements show results?

It depends on the marker. The NMN and NR trials measured higher NAD+ after 6 to 12 weeks. Creatine stores fill over about 28 days at 3g a day. The outcome trials ran for years: VITAL followed people for a median of 5.3 years. Blood tests your doctor orders, such as vitamin D, triglycerides and fasting glucose, are the practical short-term checkpoints.

Are anti-aging supplements safe to take together?

Review any combination with your doctor, especially if you take prescription medications. K2 can interfere with warfarin-type blood thinners. Berberine raised cyclosporine levels in transplant patients. NMN and NR were well tolerated in the short trials to date.

What should men look for when buying longevity supplements?

Third-party certification matters: NSF International, USP, or Informed Sport certification confirms a product contains what the label claims and has been tested for contaminants. Avoid proprietary blends with undisclosed ingredient doses. For creatine, plain monohydrate is the form used in the trials.

This article is for educational purposes only. Consult your healthcare provider before starting any new supplement regimen, particularly if you take prescription medications or have existing health conditions. The supplements discussed here are not intended to diagnose, treat, cure, or prevent any disease.